标题
Liquid biopsy: monitoring cancer-genetics in the blood
作者
关键词
-
出版物
Nature Reviews Clinical Oncology
Volume 10, Issue 8, Pages 472-484
出版商
Springer Nature
发表日期
2013-07-09
DOI
10.1038/nrclinonc.2013.110
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Phase II trial of temsirolimus alone and in combination with irinotecan forKRASmutant metastatic colorectal cancer: Outcome and results ofKRASmutational analysis in plasma
- (2013) Karen-Lise G. Spindler et al. ACTA ONCOLOGICA
- Independent Validation of a Prognostic Genomic Signature (ColoPrint) for Patients With Stage II Colon Cancer
- (2013) Matthias Maak et al. ANNALS OF SURGERY
- BRAFmutation testing algorithm for vemurafenib treatment in melanoma: recommendations from an expert panel
- (2013) D. Gonzalez et al. BRITISH JOURNAL OF DERMATOLOGY
- Noninvasive Detection of HER2 Amplification with Plasma DNA Digital PCR
- (2013) H. Gevensleben et al. CLINICAL CANCER RESEARCH
- Roles for KRAS in Pancreatic Tumor Development and Progression
- (2013) Marina Pasca di Magliano et al. GASTROENTEROLOGY
- ALKin Lung Cancer: Past, Present, and Future
- (2013) Alice T. Shaw et al. JOURNAL OF CLINICAL ONCOLOGY
- Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance
- (2013) Meghna Das Thakur et al. NATURE
- Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
- (2013) Muhammed Murtaza et al. NATURE
- Implementing personalized cancer genomics in clinical trials
- (2013) Richard Simon et al. NATURE REVIEWS DRUG DISCOVERY
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- (2013) Sarah-Jane Dawson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Utility of serum DNA and pyrosequencing for the detection of EGFR mutations in non-small cell lung cancer
- (2013) Hakan Akca et al. Cancer Genetics
- Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing
- (2013) Ellen Heitzer et al. Genome Medicine
- LOH at 6q and 10q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survival
- (2012) Jan Dominik Kuhlmann et al. BMC CANCER
- Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers
- (2012) Libero Santarpia et al. BREAST CANCER RESEARCH AND TREATMENT
- Resistance to Irreversible EGF Receptor Tyrosine Kinase Inhibitors through a Multistep Mechanism Involving the IGF1R Pathway
- (2012) A. B. Cortot et al. CANCER RESEARCH
- Cross-talk between HER2 and MED1 Regulates Tamoxifen Resistance of Human Breast Cancer Cells
- (2012) J. Cui et al. CANCER RESEARCH
- Med1 plays a critical role in the development of tamoxifen resistance
- (2012) Arumugam Nagalingam et al. CARCINOGENESIS
- Loss of Heterozygosity at Tumor Suppressor Genes Detectable on Fractionated Circulating Cell-Free Tumor DNA as Indicator of Breast Cancer Progression
- (2012) H. Schwarzenbach et al. CLINICAL CANCER RESEARCH
- Quantitative Cell-Free DNA, KRAS, and BRAF Mutations in Plasma from Patients with Metastatic Colorectal Cancer during Treatment with Cetuximab and Irinotecan
- (2012) K.-L. G. Spindler et al. CLINICAL CANCER RESEARCH
- Evaluation of Circulating Tumor Cells and Circulating Tumor DNA in Non-Small Cell Lung Cancer: Association with Clinical Endpoints in a Phase II Clinical Trial of Pertuzumab and Erlotinib
- (2012) E. A. Punnoose et al. CLINICAL CANCER RESEARCH
- Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood
- (2012) M. J. Higgins et al. CLINICAL CANCER RESEARCH
- Cancer Genome Scanning in Plasma: Detection of Tumor-Associated Copy Number Aberrations, Single-Nucleotide Variants, and Tumoral Heterogeneity by Massively Parallel Sequencing
- (2012) K. C. A. Chan et al. CLINICAL CHEMISTRY
- 479 Plasma is Superior to Serum for CfDNA Mutation Detection and Monitoring
- (2012) R.F. Andersen et al. EUROPEAN JOURNAL OF CANCER
- Translational genomics: The challenge of developing cancer biomarkers
- (2012) J. D. Brooks GENOME RESEARCH
- Influence of Chemotherapy onEGFRMutation Status Among Patients With Non–Small-Cell Lung Cancer
- (2012) Hua Bai et al. JOURNAL OF CLINICAL ONCOLOGY
- Application of a Highly Sensitive Detection System for Epidermal Growth Factor Receptor Mutations in Plasma DNA
- (2012) Tomomi Nakamura et al. Journal of Thoracic Oncology
- The prognostic value of KRAS mutated plasma DNA in advanced non-small cell lung cancer
- (2012) Anneli Dowler Nygaard et al. LUNG CANCER
- Mutations in UVSSA cause UV-sensitive syndrome and destabilize ERCC6 in transcription-coupled DNA repair
- (2012) Xue Zhang et al. NATURE GENETICS
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multi-Purpose Utility of Circulating Plasma DNA Testing in Patients with Advanced Cancers
- (2012) Geraldine Perkins et al. PLoS One
- Cancer Progression Mediated by Horizontal Gene Transfer in an In Vivo Model
- (2012) Catalina Trejo-Becerril et al. PLoS One
- Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer
- (2012) A. Kreso et al. SCIENCE
- Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
- (2012) T. Forshew et al. Science Translational Medicine
- Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome Sequencing
- (2012) R. J. Leary et al. Science Translational Medicine
- Circulating Cell-Free Nucleic Acids: Promising Biomarkers of Hepatocellular Carcinoma
- (2012) Jian Zhou et al. SEMINARS IN ONCOLOGY
- Melanoma whole-exome sequencing identifies V600E B-RAF amplification-mediated acquired B-RAF inhibitor resistance
- (2012) Hubing Shi et al. Nature Communications
- Is computed tomography follow-up of patients after lobectomy for non-small cell lung cancer of benefit in terms of survival?
- (2012) D. Srikantharajah et al. Interactive Cardiovascular and Thoracic Surgery
- Aurora-A promotes gefitinib resistance via a NF-κB signaling pathway in p53 knockdown lung cancer cells
- (2011) Chun Chi Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Applying strategies from libertarian paternalism to decision making for prostate specific antigen (PSA) screening
- (2011) David C Wheeler et al. BMC CANCER
- Circulating tumour markers can define patients with normal colons, benign polyps and cancers
- (2011) R Mead et al. BRITISH JOURNAL OF CANCER
- Detection of HER2 amplification in circulating free DNA in patients with breast cancer
- (2011) K Page et al. BRITISH JOURNAL OF CANCER
- VHL Gene Mutations and Their Effects on Hypoxia Inducible Factor HIF : Identification of Potential Driver and Passenger Mutations
- (2011) M. P. Rechsteiner et al. CANCER RESEARCH
- Quantitative Detection of EGFR Mutations in Circulating Tumor DNA Derived from Lung Adenocarcinomas
- (2011) K. Taniguchi et al. CLINICAL CANCER RESEARCH
- Tumour seeding following percutaneous needle biopsy: The real story!
- (2011) E.G. Robertson et al. CLINICAL RADIOLOGY
- Review: Incidence and clinical significance of Bevacizumab-related non-surgical and surgical serious adverse events in metastatic colorectal cancer
- (2011) D. Hompes et al. EJSO
- Genomic analysis of circulating cell-free DNA infers breast cancer dormancy
- (2011) J. A. Shaw et al. GENOME RESEARCH
- Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
- (2011) Nikhil Wagle et al. JOURNAL OF CLINICAL ONCOLOGY
- Complete Pathologic Response in Lung Tumors in Two Patients with Metastatic Non-small Cell Lung Cancer Treated with Erlotinib
- (2011) Britta Weber et al. Journal of Thoracic Oncology
- Next-generation sequencing entering the clinical arena
- (2011) Jan Haas et al. MOLECULAR AND CELLULAR PROBES
- RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
- (2011) Poulikos I. Poulikakos et al. NATURE
- Targeted therapies: how personal should we go?
- (2011) Miriam Martini et al. Nature Reviews Clinical Oncology
- High Fragmentation Characterizes Tumour-Derived Circulating DNA
- (2011) Florent Mouliere et al. PLoS One
- Controversies in clinical cancer dormancy
- (2011) J. W. Uhr et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
- (2011) L. V. Sequist et al. Science Translational Medicine
- Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer
- (2010) Ruth E. Board et al. BREAST CANCER RESEARCH AND TREATMENT
- Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC
- (2010) Alexa B. Turke et al. CANCER CELL
- Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K
- (2010) Jessie Villanueva et al. CANCER CELL
- Cell-Free Nucleic Acids Circulating in the Plasma of Colorectal Cancer Patients Induce the Oncogenic Transformation of Susceptible Cultured Cells
- (2010) D. C. Garcia-Olmo et al. CANCER RESEARCH
- Cell-free DNA in the blood as a solid tumor biomarker—A critical appraisal of the literature
- (2010) Klaus Jung et al. CLINICA CHIMICA ACTA
- Use of cancer-specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors
- (2010) David J. McBride et al. GENES CHROMOSOMES & CANCER
- Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer
- (2010) Ramon Salazar et al. JOURNAL OF CLINICAL ONCOLOGY
- Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors
- (2010) Marie Brevet et al. LUNG CANCER
- The identification of KRAS mutations at codon 12 in plasma DNA is not a prognostic factor in advanced non-small cell lung cancer patients
- (2010) Carlos Camps et al. LUNG CANCER
- COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
- (2010) Cory M. Johannessen et al. NATURE
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
- (2010) Ramin Nazarian et al. NATURE
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors
- (2010) Young Lim Choi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts
- (2010) Alain R. Thierry et al. NUCLEIC ACIDS RESEARCH
- Non-small-cell lung cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
- (2009) G. D'Addario et al. ANNALS OF ONCOLOGY
- Primary breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
- (2009) V. Kataja et al. ANNALS OF ONCOLOGY
- Isolation and Extraction of Circulating Tumor DNA from Patients with Small Cell Lung Cancer
- (2009) Ruth E. Board et al. Annals of the New York Academy of Sciences
- High quality copy number and genotype data from FFPE samples using Molecular Inversion Probe (MIP) microarrays
- (2009) Yuker Wang et al. BMC Medical Genomics
- International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee
- (2009) P F Ambros et al. BRITISH JOURNAL OF CANCER
- Single-Molecule Detection of Epidermal Growth Factor Receptor Mutations in Plasma by Microfluidics Digital PCR in Non-Small Cell Lung Cancer Patients
- (2009) T. K.F. Yung et al. CLINICAL CANCER RESEARCH
- Fine-needle aspiration (FNA) biopsy: historical aspects.
- (2009) Aristidis Diamantis et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 interpretation in breast cancer
- (2009) Sejal S. Shah et al. HUMAN PATHOLOGY
- American Society of Clinical Oncology Provisional Clinical Opinion: Testing forKRASGene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Therapy
- (2009) Carmen J. Allegra et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study
- (2009) Katherine K. Matthay et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel mutant-selective EGFR kinase inhibitors against EGFR T790M
- (2009) Wenjun Zhou et al. NATURE
- K-ras Mutations in Circulating DNA From Pancreatic and Lung Cancers
- (2009) Paolo Magistrelli et al. PANCREAS
- Influence of neuroblastoma stage on serum-based detection ofMYCNamplification
- (2009) Valerie Combaret et al. PEDIATRIC BLOOD & CANCER
- Analysis of Cancer Mutation Signatures in Blood by a Novel Ultra-Sensitive Assay: Monitoring of Therapy or Recurrence in Non-Metastatic Breast Cancer
- (2009) Zhenbin Chen et al. PLoS One
- Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer
- (2008) M. Frattini et al. CANCER LETTERS
- Improved Identification of von Hippel-Lindau Gene Alterations in Clear Cell Renal Tumors
- (2008) M. L. Nickerson et al. CLINICAL CANCER RESEARCH
- Identification of Loss of Heterozygosity on Circulating Free DNA in Peripheral Blood of Prostate Cancer Patients: Potential and Technical Improvements
- (2008) I. Muller et al. CLINICAL CHEMISTRY
- Clinical Significance ofMYCNAmplification and Ploidy in Favorable-Stage Neuroblastoma: A Report From the Children's Oncology Group
- (2008) Jennifer Schneiderman et al. JOURNAL OF CLINICAL ONCOLOGY
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
- (2008) Susan L. Cohn et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating mutant DNA to assess tumor dynamics
- (2008) Frank Diehl et al. NATURE MEDICINE
- BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models
- (2008) D Li et al. ONCOGENE
- The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
- (2008) C.-H. Yun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The concentration of deoxyribonucleic acid in plasma from 73 patients with colorectal cancer and apparent clinical correlations
- (2008) Héctor Guadalajara et al. Cancer Detection and Prevention
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started